Biopharma Veteran | Strategy, Innovation & Transformation

Where to compete.
How to win.
How to make it stick.

Michael H. Loechel helps global biopharmaceutical organizations define where to compete, build the innovation agenda that gets them there, and make large-scale change stick — bringing over 25 years of experience across strategic vision and execution discipline.

Track Record

Results measured in outcomes, not activity.

50+ Transformational initiatives led across Commercial and R&D functions for organizations including Pfizer, Amgen, Johnson & Johnson, AstraZeneca, Novo Nordisk, Boehringer Ingelheim, and Merck KGaA / EMD Serono.
$450MM+ In contract opportunities uncovered through strategic analysis.
€35MM Projected revenue increase — roughly 6–7x ROI — from a commercial capabilities advisory engagement.
Strategy

Choices that hold up under pressure.

Complex organizations do not change because a plan is well-written. They change when the strategy, the incentives, and the operating model move together. Michael's work sits at that intersection — connecting the choice of where to compete with the discipline of how a large organization actually executes.

Innovation

Creativity, applied with discipline.

Michael designs enterprise innovation agendas that connect directly to strategy and business results — not innovation for its own sake. The initiatives that follow typically show up as measurable gains: greater efficiency, simplified processes, tighter alignment between sales and marketing, and a better experience for the customer. As a Certified Applied Creativity Facilitator (Basadur) and AMA faculty member teaching Managing Chaos, he brings a structured approach to problems that do not yet have an obvious answer.